Figure 1.
Topographic markers at the NPC. Sketch of the site of GFP-POM121 (green), the binding sites of the primary antibody αNup358 (yellow), and the Alexa633-labeled secondary antibody (red). The range of geometrical binding configurations is indicated by the dashed circles, and spreads the experimentally observed label distribution by ±30 nm.